ESMO Asia 2023 Insights: "Lenvatinib vs. Sorafenib 2L Therapy in HCC Patients Progressed to Atezolizumab + Bevacizumab"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ESMO Asia 2023 Insights: "Lenvatinib vs. Sorafenib 2L Therapy in HCC Patients Progressed to Atezolizumab + Bevacizumab"

By Insights from 2023 ESMO Asia Annual Meeting FEATURING Mara Persano

57 views

January 17, 2024

0 Comments

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl

22:55

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…

Feat. R. Kim, R. Mehta

26:59

University of Texas Southwestern Medical Center

2023 AASLD Guidance for HCC

Feat. A. Singal

16:40

Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi

22:02

ACG 2023 Conference Coverage

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

Feat. R. Wong

13:58

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 &am…

Feat. R. Kim, T. Biachi

14:14

Stanford Medicine

HCC: Updates in Management

Feat. R. Dhanasekaran

14:54

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa

08:24

Yale Cancer Center

GI Oncology Year in Review: Hepatobiliary Cancers

Feat. P. Kunz

10:57

UCLA Health

Y90 Radioembolization for Locally Advanced HCC

Feat. S. Padia

28:59

The France Foundation

Evolving Options for the Treatment of HCC With IO and Liver-Directed…

Feat. A. Smolock, B. George

19:39

The France Foundation

Systemic Treatment Landscape for Advanced HCC: Case Discussion - 40 …

Feat. A. Burgoyne, S. Stein

07:19

Cleveland Clinic Taussig Cancer Institute

Clinical Implications of the HIMALAYA Study: Safety & Efficacy o…

Feat. S. Kamath

09:23

Johns Hopkins

Advancements in Systemic Therapy for Advanced HCC: Where Are We Going

Feat. M. Yarchoan

31:47

UChicago Medicine

Multidisciplinary Approach to Hepatobiliary Malignancies: A Changing…

Feat. A. A. Pillai

16:10

Malkhaz Mizandari

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing …

67:58

Scripps Health

Advances in Hepatocellular Carcinoma Diagnosis and Treatment

Feat. A. Singal

09:16

Ahmed O. Kaseb

Current Unmet Needs in Advanced HCC

05:50

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "KEYSTEP-004 Study - Coformulated Quavo…

Feat. L. Rimassa

29:25

Young Chae

Login

Login

Join VuMedi

ESMO Asia 2023 Insights: "Lenvatinib vs. Sorafenib 2L Therapy in HCC Patients Progressed to Atezolizumab + Bevacizumab"

Related Content